Rituximab maintenance therapy for patients with diffuse large B-cell lymphoma: A meta-analysis

PURPOSE: The addition of rituximab to standard chemotherapy has significantly improved survival in patients with lymphoma. Recently, maintenance therapy with rituximab has been shown to prevent relapse and provide survival benefits for patients with follicular or mantle cell lymphoma. However, the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xuan, Ma, Tingting, Zhang, Yichan, Zhou, Na, Li, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371376/
https://www.ncbi.nlm.nih.gov/pubmed/28355276
http://dx.doi.org/10.1371/journal.pone.0174648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371376/
https://www.ncbi.nlm.nih.gov/pubmed/28355276
http://dx.doi.org/10.1371/journal.pone.0174648

Ejemplares similares